Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers. - Barber-Rotenberg JS; Haas AR; Aggarwal C; O'Hara M; Hexner E; Pequignot E; Dowd E; Ndeupen S; Thai E; Chen F; Oner BS; Czuczman C; et al. (Molecular therapy : the journal of the American Society of Gene Therapy, 2026)